Hepatitis Australia monitors for news articles which have relevance to hepatitis B or hepatitis C in Australia. From time-to-time we also issue public statements and media releases which will also be shared here.
Patient safety and continuity of care is extremely important, particularly for people who have chronic and complex diseases or conditions, which is why Hepatitis Australia has joined the Continuity of Care Collaboration Read more
22 September 2020: Hepatology Nurse Practitioner, Tracey Jones, has become the first Australian nurse to be awarded the Associate Fellow designation from the American Association for the Study of Liver Diseases Read more
As Australia grapples with COVID-19 outbreaks, it is important to remember that viral hepatitis is also a pandemic. Viral hepatitis can lead to liver cancer and directly impacts nearly 360,000 people in Australia. Read more
24 July 2020 - Australia’s leading drug and infectious disease organisations will join forces to call for a re-engagement in elimination of hepatitis C in an online event on World Hepatitis Day, Tuesday, 28 July 2020. Read more
23 July 2020 - Except from article from ABC Far North about hepatitis C outbreak in Queensland correctional centre. Read more
Recent changes to the Pharmaceutical Benefits Scheme (PBS) allows authorised Nurse Practitioners to prescribe hepatitis B and hepatitis C medicines under the Highly Specialised Drugs (s100) Program. Read more
Hepatitis Australia has put together a brief factsheet with information about the coronavirus COVID-19 for people living with hepatitis B and hepatitis C. Read more
04 March 2020 - Hepatitis Australia announces appointment of new CEO Read more
The Pharmaceutical Benefits Advisory Committee will consider loosening the prescribing authority for PBS-listed hepatitis C medicines but the real focus seems to be on securing a price reduction. Read more
17 January 2020 - Hepatitis Australia announces Grant Phelps as the new President of the Board. Read more
14 November 2019: Leaders of liver disease associations from Europe, the United States, Latin America and Asia issued a global call to action at AASLD, aiming to advance toward the goal of eliminating hepatitis C as a public health threat. Read more
4 November 2019: Praise for the CEO of Hepatitis Australia Helen Tyrrell who has announced her intention to retire from the organisation she has led since 2005 Read more
4 November 2019: OTTAWA; Setting up supervised injection sites at federal institutions is the way to go says the Union of Canadian Correctional Officers. Read more
25 October 2019 - this article from The Conversation looks at why it is important to find a cure for hepatitis B, even when there is a vaccine available. Read more
19 September 2019: The NSW Food Authority issues food recall warning due to possible hepatitis A outbreak link to imported clams. Read more
10 September 2019 - The World Hepatitis Alliance (WHA) and the International Association of Providers of AIDS Care (IAPAC) announced a new partnership today on the first day of theFast-Track Cities 2019 conference in London. Read more
21 August 2019 - Changes to the immigration health requirement will have a significant and positive impact for people with hepatitis B seeking to migrate permanently to Australia. Read more
25 July 2019 - Hepatitis C has declined by a staggering 60% among people who inject drugs since new hepatitis C cures were made available Read more
25 July 2019 - We are encouraging people to take a short quiz to see if they may have been at risk of hepatitis in the past and whether they should talk to their doctor about hepatitis Read more
SHPA Chief Executive Kristin Michaels says the recent history of promising new hepatitis medicines has been a bright, albeit temporary success story. Read more
Welcome to our newly updated website. The fresh new look is easier to navigate, so finding information about hepatitis or how to get help is even simpler. Read about the new features and how to leave feedback here. Read more
The latest hepatitis C treatment data released by the Kirby Institute shows that, since March 2016, an estimated 70,260 people in Australia have commenced treatment to cure hepatitis C*. But is this enough to prevent the ongoing deaths each year in Australia from liver disease associated with hepatitis? Read more
Around 74,000 Australians have been cured of hepatitis C through the use of the direct-acting antivirals but elimination by the target date remains in doubt given the significant decline in new patient initiations. Read more
In England deaths from liver disease related to hepatitis C fell by more than 16% between 2015 and 2017, achieving the World Health Organization’s (WHO’s) target to reduce HCV-related mortality by 10% by 2020 three years early. Australia has also achieved the WHO’s 2020 mortality target. Some might say that this is good news - but at Hepatitis Australia we don’t agree. Read more